{
    "nctId": "NCT01709981",
    "officialTitle": "Anti-inflammatory Effects of Colchicine in Patients Undergoing Percutaneous Coronary Intervention: Inflammatory Marker Substudy of the Colchicine-PCI Trial",
    "inclusionCriteria": "* Patients must be more than 18 years of age and referred for coronary angiography\n* Must have minimum age of 18 Years",
    "exclusionCriteria": "* Plan for diagnostic-only coronary angiography\n* On colchicine chronically\n* History of intolerance to colchicine\n* Glomerular filtration rate \\<30mL/minute or on dialysis\n* Active malignancy or infection\n* History of myelodysplasia\n* High-dose statin load \\<24 hours prior to procedure\n* Use of oral steroids or non-steroidal anti-inflammatory agents other than aspirin within 72 hours or 3 times the agent's half-life (whichever is longer)\n* Use of strong CYP3A4/P-glycoprotein inhibitors (specifically ritonavir, ketoconazole, clarithromycin, cyclosporine, diltiazem and verapamil)\n* Unable to consent\n* Participating in a competing study"
}